Menu

News

« » View all News

NEJM Features FDA Commentary on Co-development

FDA’s Dr. Janet Woodcock writes about regimen development in the New England Journal of Medicine, noting that it is an important approach for drug development of therapies that can impact the human condition. She specifically calls out the need for information sharing through nonprofit groups and initiatives. Click here to read the article.

« » View all News